title: A novel multiple-marker method for the early diagnosis of oral squamous cell carcinoma.
abstract: OBJECTIVE
  Melanoma associated antigens-A (MAGE-A) expression is highly specific to cancer cells. Thus, they can be the most suitable targets for the diagnosis of malignancy. The aim of this study was to evaluate the sensitivity of multiple MAGE-A expression analysis for the diagnosis of oral squamous cell carcinoma (OSCC).
  
  
  METHODS
  Total of 70 OSSC and 20 normal oral mucosal (NOM) samples of otherwise healthy volunteers were examined for the expression of 10 different single antigens out of 12 different MAGE-A subtypes by highly sensitive reverse transcriptase polymerase chain reaction (RT-PCR) methods. The results were correlated to clinicopathological parameters of tumor samples.
  
  
  RESULTS
  Expression of MAGE-A was restricted to OSCC. The expression frequency of single antigen was between 10% and 55%. However, expression rate was increased up to 93% by the elevated number of genes examined. A significant correlation was found between the expression of MAGE-A and malignancy (p = 0.0001). In addition, multiple MAGE-A detection has also correlated to the incidence of lymph node metastasis, grading and advanced clinical stages.
  
  
  CONCLUSIONS
  Analysis of multiple MAGE-A expression is more sensitive than the analysis of a single MAGE-A for the diagnostic evaluation of OSCC. Multiple MAGE-A expression analysis may be a very sensitive method to be used for the diagnosis even in the early stage of OSCC.
authors.affiliation: Department of Oral and Maxillofacial Surgery, University of Erlangen, 91054 Erlangen, Germany. Jutta.Ries@uk-erlangen.de
authors.forename: Jutta
authors.initials: J
authors.lastname: Ries
authors.forename: Nur
authors.initials: N
authors.lastname: Mollaoglu
authors.forename: Takeshi
authors.initials: T
authors.lastname: Toyoshima
authors.forename: Eleftherios
authors.initials: E
authors.lastname: Vairaktaris
authors.forename: Friedrich W
authors.initials: FW
authors.lastname: Neukam
authors.forename: Sabine
authors.initials: S
authors.lastname: Ponader
authors.forename: Emeka
authors.initials: E
authors.lastname: Nkenke
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000378:metabolism*; D016022:Case-Control Studies; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000175:diagnosis* / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D012333:RNA, Messenger